Episode 116: Renal cancer surgery controversi...

Mary Ellen Taplin joins us on the heels of her ASCO 2026 Plenary presentation with this exciting phase 3 data certain to generate discussion about the landscape of high risk prostate cancer. 

Neeraj Aggarwal joins the show to discuss the phase 3 TALAPRO-3 trial of talazoparib and enzlautamide in metastatic hormone-sensitive prostate cancer, focusing on trial design, efficacy, safety, and genetic subsets. 

Dr. Rachel Frank, Director of the Joint Preservation Program, Assistant Professor at the University of Colorado School of Medicine, and complex knee and shoulder surgeonContinue readingThe post Podcast on Use of Allografts and Orthobiologics in Orthopaedic Surgery appeared first ...  Show more

Quillette podcast host Jonathan Kay speaks with New York Times opinion columnist Ross Douthat about how his new book—which explores both his own fight against chronic Lyme disease, and the controversy surrounding the condition within the medical community 

JAMA Deputy Editor and JAMA Oncology Editor Mary (Nora) L. Disis, MD, speaks with Kimmie Ng, MD, MPH, chair of the meeting's Scientific Program Committee and associate chief of the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute.

Rela ...

Dr. Brian Cole shares tips for maintaining healthy joints, focusing on non-surgical and holistic remedies.